|
2020 Journal Article Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institutionRoberts, Matthew J., Macdonald, Alastair, Ranasinghe, Sachinka, Bennett, Harrison, Teloken, Patrick E., Harris, Patrick, Paterson, David, Coughlin, Geoff, Dunglison, Nigel, Esler, Rachel, Gardiner, Robert A., Elliott, Thomas, Gordon, Louisa and Yaxley, John (2020). Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution. Prostate Cancer and Prostatic Diseases, 24 (1), 169-176. doi: 10.1038/s41391-020-0263-x |
|
2020 Journal Article 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancerRoberts, Matthew J., Morton, Andrew, Donato, Peter, Kyle, Samuel, Pattison, David A., Thomas, Paul, Coughlin, Geoff, Esler, Rachel, Dunglison, Nigel, Gardiner, Robert A., Doi, Suhail A., Emmett, Louise and Yaxley, John (2020). 68Ga-PSMA PET/CT tumour intensity pre-operatively predicts adverse pathological outcomes and progression-free survival in localised prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging, 48 (2), 655-656. doi: 10.1007/s00259-020-04944-2 |
|
2019 Journal Article Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions: a systematic review and meta-analysisPerera, Marlon, Papa, Nathan, Roberts, Matthew, Williams, Michael, Udovicich, Cristian, Vela, Ian, Christidis, Daniel, Bolton, Damien, Hofman, Michael S., Lawrentschuk, Nathan and Murphy, Declan G. (2019). Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions: a systematic review and meta-analysis. European Urology, 77 (4), 403-417. doi: 10.1016/j.eururo.2019.01.049 |
|
2015 Journal Article The emerging threat of multidrug-resistant Gram-negative bacteria in urologyZowawi, Hosam M., Harris, Patrick N. A., Roberts, Matthew J., Tambyah, Paul A., Schembri, Mark A., Pezzani, M. Diletta, Williamson, Deborah A. and Paterson, David L. (2015). The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nature Reviews Urology, 12 (10), 570-584. doi: 10.1038/nrurol.2015.199 |
|
2015 Journal Article Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancerRoberts, Matthew J., Chow, Clement W., Schirra, Horst J., Richards, Renee, Buck, Marion, Selth, Luke A., Doi, Suhail A. R., Samaratunga, Hema, Perry-Keene, Joanna, Payton, Diane, Yaxley, John, Lavin, Martin F. and Gardiner, Robert A. (2015). Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer. Prostate, 75 (5), 539-549. doi: 10.1002/pros.22942 |
|
2015 Journal Article Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysisPerera, Marlon, Roberts, Matthew J., Doi, Suhail A. R. and Bolton, Damien (2015). Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. European Urology, 67 (4), 704-713. doi: 10.1016/j.eururo.2014.10.031 |
|
2014 Journal Article Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysisRoberts, Matthew J., Williamson, Deborah A., Hadway, Paul, Doi, Suhail A. R., Gardiner, Robert A. and Paterson, David L. (2014). Baseline prevalence of antimicrobial resistance and subsequent infection following prostate biopsy using empirical or altered prophylaxis: a bias-adjusted meta-analysis. International Journal of Antimicrobial Agents, 43 (4), 301-309. doi: 10.1016/j.ijantimicag.2014.01.008 |
|
2026 Journal Article EAU–EANM–ESTRO–ESUR–ISUP–SIOG Guidelines on Prostate Cancer—2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative IntentCornford, Philip, van den Bergh, Roderick C.N., Briers, Erik, Chiu, Peter, Eberli, Daniel, Epure, Adina, Farolfi, Andrea, Fonteyne, Valérie, Gandaglia, Giorgio, Gillessen, Silke, Grivas, Nikolaos, Henry, Ann M., van Leenders, Geert J.L.H., Espinos, Estefania Linares, Matsen, Bo, Oldenburg, Jan, van Oort, Inge M., Oprea-Lager, Daniela E., Roberts, Matthew J., Rouvière, Olivier, Sachdeva, Ashwin, Santis, Maria De, Schoots, Ivo G., Smith, Emma J., Stranne, Johan, Wiegel, Thomas and Tilki, Derya (2026). EAU–EANM–ESTRO–ESUR–ISUP–SIOG Guidelines on Prostate Cancer—2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. European Urology. doi: 10.1016/j.eururo.2026.04.013 |
|
2026 Journal Article EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2026 Update: Treatment of Relapsing and Metastatic Prostate CancerTilki, Derya, van den Bergh, Roderick C.N., Briers, Erik, Chiu, Peter, Eberli, Daniel, Epure, Adina, Farolfi, Andrea, Fonteyne, Valérie, Gandaglia, Giorgio, Gillessen, Silke, Grivas, Nikolaos, Henry, Ann M., van Leenders, Geert J.L.H., Espinos, Estefania Linares, Madsen, Bo, Oldenburg, Jan, van Oort, Inge M., Oprea-Lager, Daniela E., Roberts, Matthew J., Rouvière, Olivier, Sachdeva, Ashwin, Santis, Maria De, Schoots, Ivo G., Smith, Emma J., Stranne, Johan, Wiegel, Thomas and Cornford, Philip (2026). EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2026 Update: Treatment of Relapsing and Metastatic Prostate Cancer. European Urology. doi: 10.1016/j.eururo.2026.04.014 |
|
2026 Journal Article Rethinking success in modern urologyRoberts, Matthew J. and Perera, Marlon (2026). Rethinking success in modern urology. BJU International, 138 (S2) bju.70363, S4-S5. doi: 10.1111/bju.70363 |
|
2026 Journal Article Baseline nodal status on 68Ga-PSMA-11 positron emission tomography/computed tomography in men with intermediate- to high-risk prostate cancer is prognostic for treatment failure: follow-up of the proPSMA trialHofman, Michael S., Kasivisvanathan, Veeru, Link, Emma, Buteau, James, Roberts, Matthew J., Francis, Roslyn J., Tang, Colin, Vela, Ian, Thomas, Paul, Rutherford, Natalie, Martin, Jarad M., Frydenberg, Mark, Shakher, Ramdave, Wong, Lih-Ming, Taubman, Kim, Ting Lee, Sze, Hsiao, Edward, Roach, Paul, Nottage, Michelle, Kirkwood, Ian, Hayne, Dickon, Iravani, Amir, Williams, Scott, O'Brien, Jonathan, Lawrentschuk, Nathan and Murphy, Declan G. (2026). Baseline nodal status on 68Ga-PSMA-11 positron emission tomography/computed tomography in men with intermediate- to high-risk prostate cancer is prognostic for treatment failure: follow-up of the proPSMA trial. European Urology Oncology, 9 (2), 422-429. doi: 10.1016/j.euo.2024.11.006 |
|
2026 Journal Article Prospective comparison of 64Copper [64Cu]SAR-bisPSMA vs 68Gallium[68Ga] PSMA-11 PET/CT for biochemical recurrence of prostate cancer following radical prostatectomy (Co-PSMA Trial)Khan, Sobia, Papa, Nathan, Kneebone, Andrew, Eade, Thomas, Ayati, Narjess, Nguyen, Andrew, Wong, Keith, Chen, Jeff, Ho, Bao, Idiare, Jordan, Sidhom, George, Roberts, Matthew J, Thompson, James, Sharma, Shikha, Weir, Shraddha, Devitt, Katrina, Kooner, Raji, Lieng, Hester, Rasiah, Kris, Olphert, Joanna, de Leon, Jeremy, Hruby, George, Stricker, Phillip and Emmett, Louise (2026). Prospective comparison of 64Copper [64Cu]SAR-bisPSMA vs 68Gallium[68Ga] PSMA-11 PET/CT for biochemical recurrence of prostate cancer following radical prostatectomy (Co-PSMA Trial). European Urology, 89 (6), 512-520. doi: 10.1016/j.eururo.2026.03.001 |
|
2026 Journal Article Rapid decentralized prostate cancer risk stratification by portable liquid biopsy analysis within a clinical biosensor validation frameworkKoo, Kevin M., Phillips, Grant, Srihari, Sriganesh, Farrell, Áine, Jaradi, Binny, Fitzpatrick, Kira J., Yaxley, John W., Samaratunga, Hemamali, Mainwaring, Paul N., Ru, Ke‐lin, Korbie, Darren J., Tomlins, Scott A., Roberts, Matthew J., Gardiner, Robert A. and Trau, Matt (2026). Rapid decentralized prostate cancer risk stratification by portable liquid biopsy analysis within a clinical biosensor validation framework. Advanced Science, 13 (13) e12126, e12126. doi: 10.1002/advs.202512126 |
|
2026 Conference Publication BCG plus mitomycin (BCG plus MM) versus BCG-alone as adjuvant intravesical therapy for high-risk, Non-Muscle-Invasive Bladder Cancer (NMIBC): Effects on urinary symptoms and other aspects of Health-Related Quality of Life (HRQL) in a randomised trial (BCGMM, ANZUP 1301)Hayne, D., Zhang, A. Y., Thomas, H., Krieger, L., Ischia, J., Anderson, P., Srivastav, R., Green, W., Grummet, J., Bastick, P., Beardsley, E., Blatt, A., Patel, M., Mitterdorfer, A., Roberts, M., Sengupta, S., Winter, M., Cheung, L., Hawks, C., Martin, A., Mccombie, S. P., Redfern, A. D., Davis, I. and Stockler, M. R. (2026). BCG plus mitomycin (BCG plus MM) versus BCG-alone as adjuvant intravesical therapy for high-risk, Non-Muscle-Invasive Bladder Cancer (NMIBC): Effects on urinary symptoms and other aspects of Health-Related Quality of Life (HRQL) in a randomised trial (BCGMM, ANZUP 1301). EAU26 - 41st Annual EAU Congress, London, United Kingdom, 13 - 16 March 2026. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/S0302-2838(26)00151-X |
|
2026 Conference Publication Health-related quality of life (HRQoL) outcomes with darolutamide in patients with metastatic hormone sensitive prostate cancer in the phase 3 ARANOTE trialRoberts, Matthew, Morgans, Alicia K., Haresh, Kunhi Parambath, Jievaltas, Mindaugas, Olmos, David, Shore, Neal D., Vjaters, Egils, Xing, Nianzeng, Mohamed, Ateesha F., Littleton, Natasha, Srinivasan, Shankar, Verholen, Frank and Saad, Fred (2026). Health-related quality of life (HRQoL) outcomes with darolutamide in patients with metastatic hormone sensitive prostate cancer in the phase 3 ARANOTE trial. USANZ 78th Annual Scientific Meeting, Melbourne, VIC, Australia, 28 February ‐ 3 March 2026. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. |
|
2026 Journal Article Focal therapy using a novel cooled laser device for prostate cancer: early trial resultsKam, Jonathan, Hanna, Bishoy, Jackson, Stuart, Mccombie, Stephen, Mcclintock, George, Roberts, Matthew J., Teoh, Jeremy, Arianayagam, Mohan, Canagasingham, Bertram, Goolam, Ahmed Saeed, Jeffery, Nicola, Winter, Matthew, Khadra, Mohamed, Ko, Raymond, Mehan, Nicholas, Thangasamy, Isaac and Varol, Celi (2026). Focal therapy using a novel cooled laser device for prostate cancer: early trial results. BJU International, 138 (S2), S74-S80. doi: 10.1111/bju.70150 |
|
2026 Journal Article Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how?Edmunds, Kim, Arora, Shiksha, Teppala, Sri, Scuffham, Paul, Fairbairn, David, Roberts, Matthew J., Horvath, Lisa, Smith, David P. and Tuffaha, Haitham (2026). Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how?. Familial Cancer, 25 (1) 12, 1-11. doi: 10.1007/s10689-025-00528-x |
|
2026 Journal Article bacillus calmette-guérin plus mitomycin versus bacillus calmette-guérin alone for bacillus calmette-guérin–naïve non–muscle-invasive bladder cancer: a randomised phase 3 trial (ANZUP 1301)Hayne, Dickon, Zhang, Alison Y., Thomas, Hayley, Krieger, Laurence, Ischia, Joseph, Anderson, Paul, Srivastav, Ratnesh K., Green, William, Grummet, Jeremy, Bastick, Patricia A., Beardsley, Emma K., Blatt, Alison, Patel, Manish, Chan, Lewis, Mitterdorfer, Andrew, Roberts, Matthew, Sengupta, Shomik, Winter, Matthew, Marx, Gavin, Bishop, Conrad, Cheung, Leanna, Hawks, Cynthia, Martin, Andrew, McCombie, Steve P., Redfern, Andrew D., Davis, Ian D. and Stockler, Martin R. (2026). bacillus calmette-guérin plus mitomycin versus bacillus calmette-guérin alone for bacillus calmette-guérin–naïve non–muscle-invasive bladder cancer: a randomised phase 3 trial (ANZUP 1301). European Urology, 89 (5), 446-453. doi: 10.1016/j.eururo.2026.01.009 |
|
2025 Journal Article Taking guard for the next inningsPerera, Marlon, Roberts, Matthew and Lawrentschuk, Nathan (2025). Taking guard for the next innings. BJU International, 136 (S2), S4-S4. doi: 10.1111/bju.70069 |
|
2025 Journal Article An online treatment decision aid for men with low-risk prostate cancer eligible for active surveillance and their partners increases the uptake of active surveillance: the Navigate randomised controlled trialSchofield, Penelope, Quinn, Stephen, Richards, Natalie, White, Alan, White, Fiona, Frydenberg, Mark, Chambers, Suzanne, Gordon, Louisa G., Gardiner, Robert Alexander (’Frank’), Murphy, Declan G., Roberts, Matthew J., Yaxley, John, Lawrentschuk, Nathan, Chu, Kevin, Millar, Jeremy, Grummet, Jeremy and Juraskova, Ilona (2025). An online treatment decision aid for men with low-risk prostate cancer eligible for active surveillance and their partners increases the uptake of active surveillance: the Navigate randomised controlled trial. European Urology Oncology, 8 (5), 1227-1236. doi: 10.1016/j.euo.2025.02.004 |
